Christopher James | Vice President, Investor Relations |
Joe Ciaffoni | Chief Executive Officer |
Colleen Tupper | Chief Financial Officer |
Scott Dreyer | Chief Commercial Officer |
David Amsellem | Piper Sandler |
Tim Lugo | William Blair |
Brandon Folkes | Cantor Fitzgerald |
Serge Belanger | Needham & Company |
Greg Fraser | Truist Securities |
Glen Santangelo | Jefferies |
Greetings and welcome to the Collegium Pharmaceutical First Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note that this conference call is being recorded. I will now turn the call over to Christopher James, Vice President of Investor Relations at Collegium.